Reply to: HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications
European Respiratory Journal · 2026-03 · 67 (3) · 2502523
DOI: 10.1183/13993003.02523-2025 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Respiratory Journal, online erschienen am 05.03.2026. Verfasst von Christian Kraef und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark christian.kraef.01@regionh.dk. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Extract Reply to Q. Long and Y. Li: Shareable abstract Despite limitations in representativeness and TB drug-resistance data, the RESPOND Cohort Consortium provides multicentre clinical evidence to inform clinicians and policymakers to reduce the burden of TB among people with HIV across Europe https://bit.ly/4pV1dYY
Autor:innen und Institutionen
- Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark christian.kraef.01@regionh.dk.
- Centre of Excellence for Health, Immunity and Infections, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
- Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
ORCID-Profile: Christian Kraef
Zitieren
APA
Kraef, C., Ryom, L., Kirk, O., & writing group and the RESPOND study group (2026). Reply to: HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications. European Respiratory Journal, 67(3), 2502523. https://doi.org/10.1183/13993003.02523-2025
Vancouver
Kraef C, Ryom L, Kirk O, writing group and the RESPOND study group. Reply to: HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications. European Respiratory Journal. 2026;67(3):2502523. doi:10.1183/13993003.02523-2025
BibTeX
@article{Kraef2026,
author = {Kraef, Christian and Ryom, Lene and Kirk, Ole and writing group and the RESPOND study group, writing group and the RESPOND study group},
title = {Reply to: HIV-TB risk factor assessment in Europe: methodological considerations and clinical implications},
journal = {European Respiratory Journal},
year = {2026},
volume = {67},
number = {3},
pages = {2502523},
doi = {10.1183/13993003.02523-2025}
}
EUVIMED